VAERS reports by lot

Moderna COVID-19 lot 052C21A: VAERS reports

131 VAERS reports list lot 052C21A as a Moderna COVID-19 vaccine, received between 2021-05-20 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
131
Reports
12%
Marked serious
5
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7617%
Neurological6615%
Musculoskeletal5412%
Injection-site / Local reaction5112%
Cardiac / Cardiovascular419%
Respiratory399%
Gastrointestinal389%
Dermatological (non-injection-site)297%
Allergic / Anaphylactic256%
Reproductive / Menstrual112%
Thrombotic / Hematological72%
Psychiatric / Neuropsychiatric51%

Where reports came from

U.S. state of the reporter, where given (top 12).

California29
Texas12
Michigan9
Pennsylvania8
New York8
Alabama5
Florida5
Georgia4
Louisiana4
Nevada4
New Jersey4
North Carolina3

Reports by month received

2021-051
2021-0757
2021-0825
2021-0914
2021-105
2021-112
2021-121
2022-017
2022-027
2022-033
2022-061
2022-073
2022-092
2023-111
2024-031
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.